Healthcare data exchange firm Rymedi has raised $9m in a Series A funding round to increase security and accessibility for patients. The financing came from RW3 Ventures, White Star Capital, Blockchange Ventures, Avalanche’s Blizzard Fund, and various angel investors. Rymedi offers a blockchain-based system to customers and patients that improves data transfer and entry, and maintains regulatory standards.
Y chromosome loss creates hidden cancer vulnerability in men
A study initiated by a University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu revealed that the loss of the Y chromosome in men’s body
